For the burgeoning life sciences hub that is Central Massachusetts, Governor Maura Healey’s $3.5-billion Mass Leads Act economic development proposal looks to add fuel to fires.
“Michelle offers a unique talent for leadership that will enhance the organization beyond measure,” Tye Jordan, chair of the chamber’s board of directors and regional director of Worcester-based Cinch I.T, said in the press release.
The Marlborough Economic Development Corp. has developed a new interactive tool, MapLink, to allow businesses and developers looking to invest in the city easy access to pertinent zoning information.
The primary use of the funds will be used to fund Boston Scientific’s purchase of Axonics, Inc., a $3.7-billion transaction the company announced in January.
Bruning, who has served on StageBio’s board of directors for the previous five years, has more than 25 years of experience with companies providing preclinical testing services.
Marlborough medical technology firm Boston Scientific has received approval from the U.S. Food and Drug Administration for its WaveWriter Alpha spinal cord stimulator device to be used to treat low back and leg pain deriving from a condition referred to as non-surgical back pain.